Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ferreira, Joaquim
ADOPTION, NCT04990284 / 2020-002754-24: eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.	Active, not recruiting	4	106	Europe	Opicapone, BIA 9-1067, L-DOPA/DDCI, Levodopa	Bial - Portela C S.A., Bial - Portela & Ca, S.A.	Parkinson Disease	06/23	06/23
NCT04699617: The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients	Completed	N/A	30	Europe	Dolphin 2.0	Campus Neurológico Sénior, Johns Hopkins University	Parkinson Disease	02/22	02/22
NCT06052930: Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease	Completed	N/A	30	Europe	HTC Vive™ Pro	Campus Neurológico Sénior	Parkinson Disease	08/23	08/23
Silva, Tania C
No trials found